RR Investor Alert: Richtech Robotics Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit Mar 25, 2026 2:15 PM Eastern Daylight Time RR Investor Alert: Richtech Robotics Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit Share SAN DIEGO--(BUSINESS WIRE)-- Robbins LLPreminds stockholders that a class action was filed on behalf of all investors who purchased or ...

Core Viewpoint - A class action has been filed against Richtech Robotics Inc. for allegedly misleading investors about its relationship with Microsoft, leading to significant stock price fluctuations [1][2][3]. Allegations - Richtech Robotics is accused of misrepresenting its collaboration with Microsoft, which was announced in a press release on January 27, 2026, causing a 44.6% increase in its Class B common stock price from $3.81 to $5.51 [2]. - Following a denial of the partnership by Microsoft on January 29, 2026, Richtech's stock price dropped by $1.06, or 20.87%, closing at $4.02, and further declined by $0.44, or 10.9%, to $3.58 the next day [3]. Shareholder Actions - Shareholders may participate in the class action against Richtech Robotics and must file their papers by April 3, 2026, to serve as lead plaintiff [4]. - Shareholders can remain absent class members if they choose not to participate in the case [4]. Company Background - Richtech Robotics is described as a robotics and AI technology company focused on developing advanced embodied AI systems to enhance the efficiency and productivity of U.S. businesses [1].

Core Viewpoint - A class action has been filed against Richtech Robotics Inc. for allegedly misleading investors about its relationship with Microsoft, leading to significant stock price fluctuations [1][2][3]. Group 1: Allegations and Stock Performance - Richtech Robotics announced a collaboration with Microsoft on January 27, 2026, which resulted in a 44.6% increase in its Class B common stock price, rising from $3.81 to $5.51 [2]. - Following a denial of the partnership by Microsoft on January 29, 2026, Richtech's stock fell by $1.06, or 20.87%, closing at $4.02, and further declined by $0.44, or 10.9%, to $3.58 the next day [3]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file their papers by April 3, 2026, but participation is not required to be eligible for recovery [4].

Group 1 - A class action lawsuit has been filed against Plug Power Inc. for allegedly misleading investors about its ability to receive and utilize a $1.66 billion loan from the U.S. Department of Energy (DOE) [1] - The lawsuit covers investors who purchased Plug Power securities between January 17, 2025, and November 13, 2025, and claims that the company overstated the likelihood of accessing the DOE loan funds [1] - Following the announcement of financial results on November 10, 2025, Plug Power's stock price fell by $0.09 per share, or 3.39%, closing at $2.53 per share [1] - On November 13, 2025, it was reported that Plug Power suspended its plans to construct six hydrogen production facilities, leading to a further decline in stock price by $0.48 per share, or 17.58%, closing at $2.25 per share [1] Group 2 - Robbins LLP is also involved in class action lawsuits for other companies, including Picard Medical, Inc. and Richtech Robotics Inc., indicating a broader trend of shareholder litigation in various sectors [2]

Core Viewpoint - Robbins LLP has announced a class action lawsuit against Picard Medical, Inc. for alleged fraudulent stock promotion activities that misled investors [1] Group 1: Allegations Against Picard Medical, Inc. - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [1] - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [1] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] Group 2: Stock Price Impact - On October 24, 2025, Picard Medical's stock price fell sharply by 70%, dropping to $3.99 per share [1] - Following the initial crash, the stock price has continued to decline, reaching approximately $2.00 per share [1] Group 3: Class Action Participation - Investors who purchased Picard Medical securities between September 2, 2025, and October 31, 2025, may be eligible to participate in the class action [1] - Shareholders wishing to serve as lead plaintiff must file their papers with the court by April 3, 2026 [1] - Participation in the case is not required to be eligible for recovery, allowing investors to remain absent class members if they choose [1]